Induction of natural killer cell activity in mice by injection of indomethacin
- PMID: 2432415
Induction of natural killer cell activity in mice by injection of indomethacin
Abstract
The natural killer (NK) cell system of mice in the peritoneal cavity is of very low to undetectable activity, and testing peritoneal NK cells is a useful model to study the influence of activating substances upon local injection. Injection of indomethacin at doses of 100-400 micrograms/mouse caused a marked activation of NK cell activity which was maximal at 3 days and lasted for a total of 6 days. A similar albeit less marked effect was observed with other cyclooxygenase inhibitors such as aspirin. Prostaglandin E2 reversed the activation of NK cells induced by injection of indomethacin. The cellular count of the peritoneal population was 2-fold elevated after indomethacin injection but the percentage of macrophages in the washed-out cell population was decreased from 60% (controls) to around 20%. The NK cell nature of the effector cells activated by indomethacin was substantiated by the finding that previous injection of anti-asialo GM1 antibody prevented activation. Interferon could not be detected in the peritoneal wash fluid after injection of indomethacin, suggesting interferon-independent activation. However, the possibility of small interferon quantities being locally produced could not be excluded. In further experiments we found after intraperitoneal injection of indomethacin not only cells that killed YAC-1 targets in a 4-hour assay but also killer cells that were insensitive to anti-asialo GM1 and killed P815 cells in an 18-hour assay. We assumed that these were macrophages and have done further experiments with in vitro grown bone-marrow-derived macrophages. These could be activated for killing of P815 targets by the addition of indomethacin, but (to a lesser degree) also for killing of YAC-1 lymphoma cells.
Similar articles
-
Activation of cytotoxic activity in cultures of bone marrow-derived macrophages by indomethacin.Eur J Immunol. 1987 Jan;17(1):145-8. doi: 10.1002/eji.1830170125. Eur J Immunol. 1987. PMID: 3102252
-
Activation of murine natural killer cells and macrophages by 8-bromoguanosine.J Immunol. 1988 May 1;140(9):3249-52. J Immunol. 1988. PMID: 2452203
-
Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.J Immunol. 1983 Oct;131(4):1734-41. J Immunol. 1983. PMID: 6604751
-
[Indomethacin as a modulator of the activity of natural killer cells (a review of the literature)].Vrach Delo. 1990 Aug;(8):32-6. Vrach Delo. 1990. PMID: 2256280 Review. Russian. No abstract available.
-
[Hormonal modulation of the cytotoxicity mediated by NK effectors (natural killer)].Minerva Endocrinol. 1985 Jul-Sep;10(3):175-86. Minerva Endocrinol. 1985. PMID: 2421149 Review. Italian. No abstract available.
Cited by
-
An inflammatory mediator, prostaglandin E2, in colorectal cancer.Cancer J. 2013 Nov-Dec;19(6):502-10. doi: 10.1097/PPO.0000000000000003. Cancer J. 2013. PMID: 24270349 Free PMC article. Review.
-
Age-related differences in the effect of in vivo administration of indomethacin on hemopoietic cell lineages of the spleen and bone marrow of mice.Experientia. 1992 Jul 15;48(7):674-8. doi: 10.1007/BF02118317. Experientia. 1992. PMID: 1639178
-
Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC).Mediators Inflamm. 1994;3(6):419-24. doi: 10.1155/S0962935194000591. Mediators Inflamm. 1994. PMID: 18475590 Free PMC article.
-
Role of prostanoids in gastrointestinal cancer.J Clin Invest. 2018 Jul 2;128(7):2732-2742. doi: 10.1172/JCI97953. Epub 2018 May 7. J Clin Invest. 2018. PMID: 29733297 Free PMC article. Review.
-
In vivo and in vitro induction of natural killer cells by cloned human tumor necrosis factor.Cancer Immunol Immunother. 1988;27(2):128-32. doi: 10.1007/BF00200016. Cancer Immunol Immunother. 1988. PMID: 2458181 Free PMC article.